Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
Fiche publication
Date publication
juillet 2016
Journal
The Lancet. Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DESANDES Emmanuel
Tous les auteurs :
Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, Maule MM, Merletti F, Gatta G,
Lien Pubmed
Résumé
Data from EUROCARE have consistently shown lower survival for adolescents and young adults (AYAs; aged 15-24 years) than for children (0-14 years) for most cancers that affect both groups, and modest survival improvements up to 2000-02. AYAs have longer survival than that of adults for most cancers. We used the latest definition of AYAs (aged 15-39 years) and provided estimates of 5-year relative survival for European AYAs with cancer diagnosed in 2000-07, compared with children and adults (40-69 years) with cancer, and assessed survival improvements over time.
Référence
Lancet Oncol.. 2016 Jul;17(7):896-906